Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.
The Hospital for Sick Children, Toronto and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.
J Pediatr Gastroenterol Nutr. 2018 Oct;67(4):437-440. doi: 10.1097/MPG.0000000000002093.
Pediatricians and liver specialists in the United States and Canada continue to encounter hepatitis B virus (HBV) infection in high-risk populations, including unvaccinated children, adopted children, and immigrants. Although hepatocellular carcinoma (HCC) is a known complication of HBV, there exists a paucity of data regarding the clinical presentation of HBV-associated HCC in children in these countries.
Investigators at 4 medical centers with large numbers of HBV-positive children queried their pathology and/or oncology databases to identify all cases of HBV-infected children <18 years old presenting with HCC between 1990 and 2015. Clinical data were extracted from chart review.
The group identified 8 patients, 8 to 17 years old, including 6 (75%) males. All individuals were assumed to be infected through vertical transmission. Three (38%) presented initially to the emergency room, 2 (25%) to a general pediatrician, 1 (13%) to a hepatologist, and the initial location was not documented in 2 (25%) cases. Three patients were asymptomatic, but the most common symptoms were abdominal pain (50%) and fatigue (38%). Hepatomegaly was present in 5 (63%) patients. Viral load was not documented in any patient. Only 3 patients had their HBeAg status documented and all individuals were HBeAg(-) and anti-HBe(+). Aspartate aminotransferase (AST) ranged from 13 to 575 IU/L, and alanine aminotransferase (ALT) ranged from 14 to 212 IU/L; 4 patients had AST and ALT < 1.5 times the upper limit of normal. Three patients had elevated bilirubin and gamma glutamyl transpeptidase (GGT), and 3 had normal bilirubin and GGT; 1 patient had unknown bilirubin and a separate patient had unknown GGT. Alpha-fetoprotein (AFP) was elevated in 3 patients (range 2.556-7.600 ng/mL), normal in 2 patients, and not documented in 3 patients. Ultrasound was initially used to identify the tumor in 5 patients whereas computerized axial tomography scan was used in 3 patients. Six patients had multiple nodules on initial imaging.
Although rare, HBV-associated HCC occurs in young children, often with normal liver enzymes, bilirubin, GGT, and AFP. Only routine imaging with ultrasound or computerized axial tomography scan consistently identified the tumor. These data may help inform screening for HCC including age of initiation and the role for imaging over laboratory testing.
美国和加拿大的儿科医生和肝脏专家在高危人群中继续发现乙型肝炎病毒(HBV)感染,包括未接种疫苗的儿童、被收养的儿童和移民。虽然肝细胞癌(HCC)是 HBV 的已知并发症,但在这些国家,关于儿童中与 HBV 相关的 HCC 的临床表现的数据很少。
4 家拥有大量 HBV 阳性儿童的医疗中心的研究人员查询了他们的病理学和/或肿瘤学数据库,以确定 1990 年至 2015 年间所有年龄在 18 岁以下、患有 HBV 感染并患有 HCC 的儿童病例。从病历回顾中提取临床数据。
该组共确定了 8 名 8 至 17 岁的患者,其中 6 名(75%)为男性。所有人都假定是通过垂直传播感染的。3 名(38%)最初到急诊室就诊,2 名(25%)到儿科医生就诊,1 名(13%)到肝病专家就诊,2 名(25%)患者的初始位置未记录。3 名患者无症状,但最常见的症状是腹痛(50%)和疲劳(38%)。5 名(63%)患者有肝肿大。没有记录任何患者的病毒载量。只有 3 名患者的 HBeAg 状态有记录,所有患者均为 HBeAg(-)和抗-HBe(+)。天门冬氨酸氨基转移酶(AST)范围为 13 至 575IU/L,丙氨酸氨基转移酶(ALT)范围为 14 至 212IU/L;4 名患者的 AST 和 ALT 低于正常上限的 1.5 倍。3 名患者胆红素和γ-谷氨酰转肽酶(GGT)升高,3 名患者胆红素和 GGT 正常;1 名患者胆红素未知,另一名患者 GGT 未知。3 名患者甲胎蛋白(AFP)升高(范围 2.556-7.600ng/mL),2 名患者正常,3 名患者未记录。5 名患者最初使用超声检查发现肿瘤,3 名患者使用计算机轴向断层扫描(CT)检查。6 名患者在初次成像时有多个结节。
尽管罕见,但 HBV 相关 HCC 发生在幼儿中,常伴有正常的肝酶、胆红素、GGT 和 AFP。只有常规的超声或 CT 扫描才能始终如一地发现肿瘤。这些数据可能有助于为 HCC 提供信息,包括起始年龄以及影像学在实验室检测中的作用。